Contents

Current Neuropharmacology, Volume 14 - Number 2


Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference Behavior

, 14(2): 118 - 142

Ewa Bojanowska and Joanna Ciosek


DOI: 10.2174/1570159X14666151109103147



Mitochondrial Biology and Neurological Diseases

, 14(2): 143 - 154

Siddharth Arun, Lei Liu and Gizem Donmez


DOI: 10.2174/1570159X13666150703154541



LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals

, 14(2): 155 - 164

Miryam Nava Catorce and Goar Gevorkian


DOI: 10.2174/1570159X14666151204122017



Kappa Opioids, Salvinorin A and Major Depressive Disorder

, 14(2): 165 - 176

George T. Taylor and Francesca Manzella


DOI: 10.2174/1570159X13666150727220944



Alzheimer’s Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy Outcome

, 14(2): 177 - 190

A. Giulietti, A. Vignini, L. Nanetti, L. Mazzanti, R. Di Primio and E. Salvolini


DOI: 10.2174/1570159X13666150928155321



The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review

, 14(2): 191 - 199

Antonio Bruno, Paolo Morabito, Edoardo Spina and Maria Rosaria Muscatello


DOI: 10.2174/1570159X14666151117122458



Memantine and Kynurenic Acid: Current Neuropharmacological Aspects

, 14(2): 200 - 209

Zsófia Majláth, Nóra Török, József Toldi and László Vécsei


DOI: 10.2174/1570159X14666151113123221




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science